Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings.

                    The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and/or contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with grant and/or contract proposals applications, the                           ( print page 64849)                        disclosure of which would constitute a clearly unwarranted invasion of personal privacy.                

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel;  Improving the Reach and Quality of Cancer Care in Rural Populations                    

*Date:*                         January 18, 2019.                    

*Time:*                         7:30 a.m. to 5:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Bethesda North Marriott Hotel & Conference Center, 5701 Marinelli Road, North Bethesda, MD 20852.                    

*Contact Person:*                         Clifford W. Schweinfest, Ph.D., Scientific Review Officer,  Special Review Branch Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W108 Bethesda, MD 20892-9750, 240-276-6343,                         *schweinfestcw@mail.nih.gov.*

*Name of Committee:*                         National Cancer Institute, Special Emphasis Panel;  NCI SPORE II (P50).                    

*Date:*                         January 29-30, 2019.                    

*Time:*                         8:30 a.m. to 5:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Gaithersburg Marriott Washingtonian Center, 9751 Washingtonian Boulevard, Gaithersburg, MD 20878.                    

*Contact Person:*                         Wlodek Lopaczynski, M.D., Ph.D., Scientific Review Officer,  Office of the Director, Division of Extramural Activities, National Cancer Institute, NIH 9609 Medical Center Drive, Room 7W514, Bethesda, MD 20892-9750 240-276-6340,                         *lopacw@mail.nih.gov.*

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel;  SEP-5: NCI Clinical and Translational R21 and Omnibus R03.                    

*Date:*                         February 1, 2019.                    

*Time:*                         8:00 a.m. to 5:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue Bethesda, MD 20814.                    

*Contact Person:*                         Robert S. Coyne, Ph.D.,  Scientific Review Officer,  Special Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W236, Bethesda, MD 20892-9750 240-276-5120,                         *coyners@mail.nih.gov.*

*Name of Committee:*                         National Cancer Institute, Special Emphasis Panel;  Quantitative Imaging Tools and Methods for Cancer Therapy Response Assessment.                    

*Date:*                         February 1, 2019.                    

*Time:*                         11:00 a.m. to 3:30 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Cancer Institute, Shady Grove, 9609 Medical Center Drive, Room 7W640, Rockville, MD 20850 (Telephone Conference Call).                    

*Contact Person:*                         Saejeong J. Kim, Ph.D., Scientific Review Officer,  Special Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W640, Bethesda, MD 20892-9750, 240-276-5179,                         *saejeong.kim@nih.gov.*

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel;  SEP-3: NCI Clinical and Translational R21 and Omnibus R03.                    

*Date:*                         February 7-8, 2019.                    

*Time:*                         4:00 p.m. to 5:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Bethesda North Marriott Hotel & Conference Center, 5701 Marinelli Road, North Bethesda, MD 20852.                    

*Contact Person:*                         Ombretta Salvucci, Ph.D.,  Scientific Review Officer,  Special Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W264, Bethesda, MD 20892-9750, 240-276-7286,                         *salvucco@mail.nih.gov.*

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel;  TEP-3: SBIR Contract Review.                    

*Date:*                         February 13-14, 2019.                    

*Time:*                         10:00 a.m. to 2:00 p.m.                    

*Agenda:*                         To review and evaluate contract proposals.                    

*Place:*                         National Cancer Institute, Shady Grove, 9609 Medical Center Drive, Room 2W032, Rockville, MD 20850 (Telephone Conference Call).                    

*Contact Person:*                         Eduardo E. Chufan, Ph.D.,  Scientific Review Officer,  Research Technology and Contract Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W254, Bethesda, MD 20892-9750, 240-276-7975,                         *chufanee@mail.nih.gov.*

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel;  Biological Comparisons in Patient-Derived Models of Cancer.                    

*Date:*                         February 22, 2019.                    

*Time:*                         1:00 p.m. to 3:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Cancer Institute, Shady Grove, 9609 Medical Center Drive, Room 7W236, Rockville, MD 20850 (Telephone Conference Call).                    

*Contact Person:*                         Robert S. Coyne, Ph.D.,  Scientific Review Officer,  Special Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W236, Bethesda, MD 20892-9750, 240-276-5120,                         *coyners@mail.nih.gov.*

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel;  SEP-7: NCI Clinical and Translational R21 and Omnibus R03.                    

*Date:*                         February 28, 2019.                    

*Time:*                         7:30 a.m. to 5:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Bethesda North Marriott Hotel & Conference Center, 5701 Marinelli Road, North Bethesda, MD 20852.                    

*Contact Person:*                         Saejeong J. Kim, Ph.D.,  Scientific Review Officer,  Special Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W640, Bethesda, MD 20892-9750, 240-276-2432,                         *saejeong.kim@nih.gov.*

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel;  NCORP Research Bases.                    

*Date:*                         March 5, 2019.                    

*Time:*                         8:00 a.m. to 5:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Cancer Institute, Shady Grove, 9609 Medical Center Drive, Room 7W032/034, Rockville, MD 20850.                    

*Contact Person:*                         Michael B. Small, Ph.D., Scientific Review Officer,  Program and Review Extramural Staff Training Office, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W412, Bethesda, MD 20892-9750, 240-276-6384,                         *smallm@mail.nih.gov.*

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel;  Community Oncology Research Program—Community Sites.                    

*Date:*                         March 7-8, 2019.                    

*Time:*                         8:00 a.m. to 5:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Cancer Institute, Shady Grove, 9609 Medical Center Drive, Room TE406, Rockville, MD 20850.                    

*Contact Person:*                         Timothy C. Meeker, M.D., Ph.D.,  Scientific Review Officer,  Resources and Training Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W606, Bethesda, MD 20892-9750, 240-276-6464,                         *meekert@mail.nih.gov.*

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel;  SEP-1 for Provocative Questions.                    

*Date:*                         March 7, 2019.                    

*Time:*                         8:00 a.m. to 5:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Bethesda North Marriott Hotel & Conference Center, 5701 Marinelli Road, North Bethesda, MD 20852.                    

*Contact Person:*                         Hasan Siddiqui, Ph.D. , Scientific Review Officer,  Special Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W240, Bethesda, MD 20892-9750, 240-276-5122,                         *hasan.siddiqui@nih.gov.*

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel;  SEP-6: NCI Clinical and Translational R21 and Omnibus R03.                    

*Date:*                         March 7-8, 2019.                    

*Time:*                         5:00 p.m. to 4:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Bethesda North Marriott Hotel & Conference Center, 5701 Marinelli Road, North Bethesda, MD 20852.                    

*Contact Person:*                         Eduardo E. Chufan, Ph.D.,  Scientific Review Officer,  Research Technology and Contract Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W254, Bethesda, MD 20892-9750, 240-276-7975,                         *chufanee@mail.nih.gov.*

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel SEP-4 for Provocative Questions.                    

*Date:*                         March 14-15, 2019.                    

*Time:*                         6:00 p.m. to 3:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                              ( print page 64850)    

*Place:*                         Hilton Washington DC/Rockville Hotel, 1750 Rockville Pike, Rockville, MD 20852.                    

*Contact Person:*                         Clifford W. Schweinfest, Ph.D., Scientific Review Officer,  Special Review Branch Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W108, Bethesda, MD 20892-9750, 240-276-6343,                         *schweinfestcw@mail.nih.gov.*

*Name of Committee:*                         National Cancer Institute, Special Emphasis Panel SEP-3 for Provocative Questions.                    

*Date:*                         March 21, 2019.                    

*Time:*                         7:30 a.m. to 4:30 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Hilton Washington DC/Rockville Hotel, 1750 Rockville Pike, Rockville, MD 20852.                    

*Contact Person:*                         Hasan Siddiqui, Ph.D.,  Scientific Review Officer, Special Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W240 Bethesda, MD 20892-9750, 240-276-5122,                         *hasan.siddiqui@nih.gov.*

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel TEP-9: Clonogenic High-Throughput Assay for Anti-Cancer Agents and Radiation Modulators.                    

*Date:*                         March 28, 2019.                    

*Time:*                         10:00 a.m. to 3:00 p.m.                    

*Agenda:*                         To review and evaluate contract proposals.                    

*Place:*                         National Cancer Institute, Shady Grove, 9609 Medical Center Drive, Room 7W246 Rockville, MD 20850.                    

*Contact Person:*                         Jun Fang, Ph.D.,  Scientific Review Officer,  Research Technology and Contract Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W260, Bethesda, MD, 20892-9750 240-276-5460,                         *jfang@mail.nih.gov.*

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS)

Dated: December 11, 2018.

Melanie J. Pantoja,

Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2018-27178 Filed 12-17-18; 8:45 am]

 BILLING CODE 4140-01-P